http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Zhang T.,Du W.Y.,Zhan C.Y.,Wang M.M.,Deng H.W.,Xie Z.M.,Li H. 한국원자력학회 2022 Nuclear Engineering and Technology Vol.54 No.8
The synergistic effect of ZrC nanoparticle pining and Re solution in W matrix on the thermal stability of tungsten was studied by investigating the evolution of the microstructure, hardness and tensile properties after annealing in a temperature range of 1000e1700 C. The results of metallography, electron backscatter diffraction pattern and Vickers micro-hardness indicate that the rolled W-1wt%Re-0.5 wt% ZrC alloy has a higher recrystallization temperature (1600 Ce1700 C) than that of the rolled pure W (1200 C), W-0.5 wt%ZrC (1300 C), W-0.5 wt%HfC (1400e1500 C) and WeK-3wt%Re alloy fabricated by the same technology. The molecular dynamics simulation results indicated that solution Re atoms in W matrix can slow down the self-diffusion of W atoms and form dragging effect to delay the growth of W grain, moreover, the diffusion coefficient decrease with increasing Re content. In addition, the ZrC nanoparticles can pin the grain boundaries and dislocations effectively, preventing the recrystallization. Therefore, synergistic effect of solid solution Re element and dispersed ZrC nanoparticles significantly increase recrystallization temperature
Production of Chitosan- and Chitin-like Exopolymers by Acetobacter xylinum ATCC 10245
Lee,Jin W.,Deng,Fang,Yeomans,Walter G.,Allen,Alfred L.,Gross,Richard A.,Kaplan,David L. 한국생명과학회 1998 한국생명과학회 학술발표회 Vol.20 No.-
To biosynthesize modified cellulose, glucose analogs including 3-O-methyl-D-glucose, glucosamine, N-acetylglucosamine, and 2-deoxy-D-glucose were used separately as the carbon source. Incorporation of glucosamine and N-acetylglucosamine repeat units into cellulose by Acetobacter xylinum ATCC 10245 was confirmed by GC, GC/MS, FTIR and ¹H-NMR. Based on data, the average molar percentages of glucosamine and N-acetylglucosamine repeat units into exopolymers were 19% and 18%, respectively. The yields of exopolymers made with glucosamine and N-acetylglucosamine as carbon source after 7 day culture were 0.37 ㎎/㎖ and 0.67 ㎎/㎖ , respectively, whereas that of glucose was 3.9 ㎎/㎖. The yield of exopolymer made with the mixture of glucose (0.5%, v/v) and glucosamine (1.5%, v/v) as carbon sources was 1.75 ㎎/㎖, and the average molar percentage of glucosamine repeat unit into the exopolymer was 17%. Exopolymers made with glucosamine and N-acetylglucosamine were fractionated by 10% acetic acid and DW, respectively, The molar ratio of glucose to glucosamine in the acetic acid (10%, v/v) soluble fractionation of glucosamine incorporated exopolymer was 0.6: 1.0. The molar ratio of glucose to N-acetylglucosanune in the water soluble fraction of N-acetylglucosamine incorporated exopolymer was 0.8 : 1.0.
Biosynthesis of Novel Exopolymers by Aureobasidium pullulans
Lee,Jin W.,Deng,Fang,Yeomans,Walter G.,Allen,Alfred L.,Gross,Richard A.,Kaplan,David L. 한국생명과학회 1998 한국생명과학회 학술발표회 Vol.20 No.-
Exopolymers produced by A. pullulans ATCC 42023 under aerobic conditions with glucose, mannose, and glucose analogs including 3-O- methyl-D-glucose, glucosamine, N-acetylglucosamine, and 2-deoxy-D- glucose as carbon sources contained glucose and mannose. The molar ratio of glucose to mannose in exopolymers and the molecular weight of exopolymers varied with the carbon source and culture time. Exopolymers synthesized with glucose and mannose as carbon sources showed glucose contents of 87±3 and 89±2%, respectively, with a decreased molecular weight from 3.50 - 2.12 x 10^6 to 0.85 - 0.77 x 10^6 with culture time. The molar ratio of glucose to mannose in the exopolymer synthesized with glucosamine changed from 55±3 : 45±3 to 29±2 : 71±2 and its molecular weight increased from 2.73 x 10^6 to 4.86 x10^6 with culture time. The molar ratio of glucose to mannose in exopolymers ranged from 87±3 : 13±3 to 28±2 : 72±2 and can be controlled by carbon source. On the basis on the results from enzyme hydrolysis of the exopolymers and comparison of ¹H- and ^(13)C-NMR chromatograms, the mannose as a monomeric component is substituted for glucose without changing the structure of pullulan.
( Jp Bronowicki ),( M Davis ),( S Flamm ),( S Gordon ),( E Lawitz ),( E Yoshida ),( J Galati ),( V Luketic ),( J Mccone ),( Jacobson ),( P Marcellin ),( A Muir ),( F Poordad ),( Ld Pedicone ),( W Deng 대한간학회 2012 춘·추계 학술대회 (KASL) Vol.2012 No.1
Background: Patients in the PR control arms of BOC Phase 2/3 studies who did not achieve SVR could enroll in PROVIDE and receive BOC+PR. This interim analysis examines the preliminary efficacy and safety of BOC+PR in patients who failed prior treatment with PR. Methods: BOC (800 mg TID with food) was given with P 1.5 mcg/kg/week and weight-based R (600-1400 mg/day) BID for up to 44 weeks. If >2 weeks had elapsed since end of treatment in the previous study, PR was given for 4 weeks before adding BOC. Protocol specified analyses include patients who received at least one dose of BOC. Denominators for on-treatment response include patients who reached the specific time point or discontinued. The denominators for SVR include all patients who reached end of follow-up, discontinued, or were treatment failures. Results: Characteristics of 168 enrolled patients were: 67% male, 84% Caucasian, mean age 52 years, mean BMI 27.9 kg/m2, 77% high viral load (>800,000 IU/mL; mean log10 6.26); 10% cirrhotic; 61% subtype 1a. Table shows the proportion of BOC treated patients with undetectable HCV RNA at tested time points. SVR was achieved in 40% of prior null responders (<2 log10 decline in HCV RNA at TW12 in prior study) and 68% of prior partial responders/relapsers; 78% (38/49) of prior null responders and 24% (26/107) of prior partial responders/ relapsers had <1 log10 decline in HCV RNA after the PR lead in. Overall SVR was 47% in patients with <1 log10 decline with lower SVR rates in prior null responders (36%) vs. prior partial responders/relapsers (65%). 68% of patients with >1 log decline achieved SVR (55% prior null responders; 70% prior partial responders/relapsers). Seven percent of patients discontinued due to AEs, while 48% experienced anemia, 34% dysgeusia and 22% neutropenia. Conclusions: BOC+PR achieved high SVR rates regardless of prior response to PR. The degree of interferon responsiveness after PR lead in correlates with prior response and can help predict SVR for prior null responders. The safety profile is comparable to that previously reported for BOC+PR.
Yi-Xiáng J Wáng,James F Griffith,Min Deng,David KW Yeung,Jing Yuan 대한영상의학회 2015 Korean Journal of Radiology Vol.16 No.1
Bilateral oophorectomy leads to reduced bone mineral density (BMD), and reduced BMD is associated with increased marrow fat and reduced marrow perfusion. Purpose of this study was to investigate how soon these changes occur following surgical oophorectomy. Six patients who underwent hysterectomy and bilateral salpingo-oophorectomy were studied. At baseline, mean patient age was 49.5 years (range: 45–54 years). Third lumbar vertebral body BMD measurement using quantitative CT, marrow fat fraction (FF) using MR spectroscopy and marrow perfusion using dynamic contrast enhanced MRI were conducted immediately prior to surgery and at 3, 9, and 21 months after surgery. Reduced BMD, increased marrow FF, and reduced marrow perfusion occurred synchronously post-oophorectomy. There was a sharp decrease of 12.5 ± 7.2% in BMD (n = 6), a sharp increase of 92.2 ± 46.3% (n = 6) in FF, a sharp decrease of 23.6 ± 3.9% in maximum contrast enhancement (n = 5), and of 45.4 ± 7.7% for enhancement slope (n = 5) during the initial 3 months post surgery. BMD and marrow perfusion continued to decrease, and marrow FF continued to increase at a slower rate during the following 18 months. Friedman test showed a significant trend for these changes (p < 0.05). Bilateral oophorectomy leads to a rapid decrease in lumbar BMD, an increase in marrow fat content, and a decrease in marrow blood perfusion.